2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Machado-Neto, JA; Paiva, HH; Rego, EM; Rodrigues Alves, AP; Scheucher, PS; Simões, BP; Traina, F | 1 |
1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Reversine triggers mitotic catastrophe and apoptosis in K562 cells.
Topics: Apoptosis; Aurora Kinase A; Aurora Kinase B; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitosis; Morpholines; Protein Kinase Inhibitors; Purines | 2016 |